Works matching IS 1742464X AND DT 2021 AND VI 288 AND IP 21

Results: 16

In Conversation with Tony Letai.

Published in:

FEBS Journal, 2021, v. 288, n. 21, p. 6087, doi. 10.1111/febs.16229

By:

Skourti, Eleni;
Letai, Anthony

Publication type:

Article

The ever‐expanding landscape of cancer therapeutic approaches.

Published in:: FEBS Journal, 2021, v. 288, n. 21, p. 6082, doi. 10.1111/febs.16228
Publication type:: Article

Calcium signaling in cancer progression and therapy.

Published in:

FEBS Journal, 2021, v. 288, n. 21, p. 6187, doi. 10.1111/febs.16133

By:

Wu, Ling;
Lian, Weidong;
Zhao, Liang

Publication type:

Article

Pediatric high‐grade glioma: moving toward subtype‐specific multimodal therapy.

Published in:

FEBS Journal, 2021, v. 288, n. 21, p. 6127, doi. 10.1111/febs.15739

By:

Chatwin, Hannah V.;
Cruz Cruz, Joselyn;
Green, Adam L.

Publication type:

Article

Quantitative imaging and dynamics of tumor therapy with viruses.

Published in:

FEBS Journal, 2021, v. 288, n. 21, p. 6273, doi. 10.1111/febs.16102

By:

Kemler, Iris;
Karamched, Bhargav;
Neuhauser, Claudia;
Dingli, David

Publication type:

Article

Tumor‐associated macrophages in immunotherapy.

Published in:

FEBS Journal, 2021, v. 288, n. 21, p. 6174, doi. 10.1111/febs.15726

By:

Yan, Shijia;
Wan, Guohui

Publication type:

Article

Role of the runt‐related transcription factor (RUNX) family in prostate cancer.

Published in:

FEBS Journal, 2021, v. 288, n. 21, p. 6112, doi. 10.1111/febs.15804

By:

Ashe, Hannah;
Krakowiak, Patryk;
Hasterok, Sylwia;
Sleppy, Rosalie;
Roller, Devin G.;
Gioeli, Daniel

Publication type:

Article

Druggable genome and precision medicine in cancer: current challenges.

Published in:

FEBS Journal, 2021, v. 288, n. 21, p. 6142, doi. 10.1111/febs.15788

By:

Dupont, Camille Amandine;
Riegel, Kristina;
Pompaiah, Malvika;
Juhl, Hartmut;
Rajalingam, Krishnaraj

Publication type:

Article

Engineering soluble T‐cell receptors for therapy.

Published in:

FEBS Journal, 2021, v. 288, n. 21, p. 6159, doi. 10.1111/febs.15780

By:

Robinson, Ross A.;
McMurran, Catriona;
McCully, Michelle L.;
Cole, David K.

Publication type:

Article

Oncogenic dysregulation of pre‐mRNA processing by protein kinases: challenges and therapeutic opportunities.

Published in:

FEBS Journal, 2021, v. 288, n. 21, p. 6250, doi. 10.1111/febs.16057

By:

Naro, Chiara;
Bielli, Pamela;
Sette, Claudio

Publication type:

Article

Development of new therapeutic options for the treatment of uveal melanoma.

Published in:

FEBS Journal, 2021, v. 288, n. 21, p. 6226, doi. 10.1111/febs.15869

By:

Wang, Janney Z.;
Lin, Vivian;
Toumi, Elsa;
Wang, Ke;
Zhu, Hong;
Conway, R. Max;
Madigan, Michele C.;
Murray, Michael;
Cherepanoff, Svetlana;
Zhou, Fanfan;
Shu, Wenying

Publication type:

Article

Targeting dormant tumor cells to prevent cancer recurrence.

Published in:

FEBS Journal, 2021, v. 288, n. 21, p. 6286, doi. 10.1111/febs.15626

By:

Damen, Maartje P. F.;
van Rheenen, Jacco;
Scheele, Colinda L. G. J.

Publication type:

Article

New insights into the activities and toxicities of the old anticancer drug doxorubicin.

Published in:

FEBS Journal, 2021, v. 288, n. 21, p. 6095, doi. 10.1111/febs.15583

By:

van der Zanden, Sabina Y.;
Qiao, Xiaohang;
Neefjes, Jacques

Publication type:

Article

Table of Contents.

Published in:: FEBS Journal, 2021, v. 288, n. 21, p. 6304, doi. 10.1111/febs.15417
Publication type:: Article

Issue Information.

Published in:: FEBS Journal, 2021, v. 288, n. 21, p. 6079, doi. 10.1111/febs.15416
Publication type:: Article

Tools to study and target the Siglec–sialic acid axis in cancer.

Published in:

FEBS Journal, 2021, v. 288, n. 21, p. 6206, doi. 10.1111/febs.15647

By:

Läubli, Heinz;
Kawanishi, Kunio;
George Vazhappilly, Cijo;
Matar, Rachel;
Merheb, Maxime;
Sarwar Siddiqui, Shoib

Publication type:

Article